“Repeat-dose toxicity studies with mipomersen were performed using a subcutaneous injection for time intervals of 3 and 6 months in mice, 13 weeks and 5 months in rats, and 5 weeks, 13 weeks, and 12 months in cynomolgus monkeys.”
SC: 3- and 6-month mouse, 5-month rat, 13-week (SC/IV) and 1-year monkey; 2-year mouse and rat carcinogenicity
“Repeat-dose toxicity studies with mipomersen were performed using a subcutaneous injection for time intervals of 3 and 6 months in mice, 13 weeks and 5 months in rats, and 5 weeks, 13 weeks, and 12 months in cynomolgus monkeys.”
Subcutaneous (clinical route); IV infusion arm in 13-week monkey study
“A 13-Week Toxicity Study and Pharmacokinetic Study of ISIS 301012 Administered by Intravenous Infusion or Subcutaneous Injection to Cynomolgus Monkeys, with a 13-Week Recovery Period”
✓ VerifiedFDA pharmacology/toxicology review, p. 35Source ↗